Integra Lifesciences Holdings Corp reports results for the quarter ended June 30 - Earnings Summary

• Integra Lifesciences Holdings Corp IART reported quarterly adjusted earnings of 45 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 63 cents. The mean expectation of eleven analysts for the quarter was for earnings of 43 cents per share. Wall Street expected results to range from 42 cents to 46 cents per share.

• Revenue fell 0.6% to $415.61 million from a year ago; analysts expected $395.07 million.

• Integra Lifesciences Holdings Corp's reported EPS for the quarter was a loss of $6.31​.

• The company reported a quarterly loss of $484.07 million.

• Integra Lifesciences Holdings Corp shares had risen by 0.8% this quarter and lost 45.5% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 24.6% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy," 6 "hold" and 4 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for Integra Lifesciences Holdings Corp is $13.00, about 4.8% above its last closing price of $12.37

This summary was machine generated from LSEG data July 31 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)